from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3219/whiB1

LFCtreatmentdescriptionclass of inhibitor

1.825

Amikacinug/mL Amikacintranslation

1.447

Cap5-10ug/mL Capreomycintranslation

1.403

Rox10-50 ug/mL Roxithromycintranslation

1.127

SM2-5 ug/mL Streptomycintranslation

1.597

Tet5-10 ug/mL Tetracyclinetranslation

-1.351

Rif0.2-5ug/mL Rifampicintranscription

-0.390

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.570

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-1.458

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.916

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.123

Clofazimine10-13 ug/mL Clofaziminerespiration

0.177

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.226

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-2.528

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.586

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.348

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.167

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.202

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.364

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.084

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.910

KCN5-20 ug/mL Potassium cyaniderespiration

0.422

NaN30.2-2 mM Sodium aziderespiration

0.594

Nigericin50 uM Nigericinrespiration

-1.495

TRC10-150 ug/mL Triclosanrespiration

-1.723

TRZ10-25 ug/mL Thioridazinerespiration

0.150

Valinomycin0.5-10 uM Valinomycinrespiration

0.641

ZnSO42 mM ZnSO4respiration

0.103

menadione6-10 ug/mL Menadionerespiration

0.618

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.365

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.831

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.338

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.222

NRP_1Non-replicating persistence stage 1dosRassociated

0.307

Amp0.2mg/mL AmpicillincellWall

-0.051

Cephalexin20-100 ug/mL CephalexincellWall

1.007

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.075

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.388

EMB10-20 ug/mL EthambutolcellWall

1.284

Eta12-40 ug/mL EthionamidecellWall

1.530

INH0.2-0.4 ug/mL IsoniazidcellWall

0.564

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.130

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.209

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.702

BZA0.12 mg/mL BenzamidearomaticAmides

-0.862

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.138

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.209

H2O24 mM hydrogen peroxideDNAdamaging

-0.096

Levo10 ug/mL LevofloxacinDNAdamaging

0.491

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.232

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.185

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.240

UVUV-irradiationDNAdamaging

0.084

ARP41-4 ug/mL Antitubercular compound ARP4?

0.169

Antimycin12.5-50 ug/mL Antimycin A?

0.093

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.170

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.002

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.304

PA8240.2-2 ug/mL PA-824?

0.400

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.016

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.105

Verapamil50 uM Verapamil?

0.242

mercaptoethanol2 mM 2-Mercaptoethanol?

0.339

methoxatin10-20 ug/mL Methoxatin?